Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRESY
4876
Cresud
CRESY
$800M
| $197K | ﹤0.01% |
35,541
+14,224
| +67% | +$108K |
|
4877
CALL
Henry Schein
HSIC
$9.9B
| $197K | ﹤0.01% |
3,100
-10,500
| -77% | -$678K |
|
4878
International Money Express
IMXI
$375M
| $197K | ﹤0.01% |
14,402
-24,072
| -63% | -$337K |
|
4879
CytomX Therapeutics
CTMX
$686M
| $196K | ﹤0.01% |
26,519
-8,809
| -25% | -$86.9K |
|
4880
CALL
Teekay
TK
$1.02B
| $196K | ﹤0.01% |
48,900
+35,400
| +262% | +$142K |
|
|
ESV
4881
CALL
DELISTED
Ensco Rowan plc
ESV
| $196K | ﹤0.01% |
40,650
-6,325
| -13% | -$52.4K |
|
4882
Bank First Corp
BFC
$1.73B
| $194K | ﹤0.01% |
2,941
-2,183
| -43% | -$133K |
|
4883
Caesarstone
CSTE
$75.4M
| $194K | ﹤0.01% |
11,701
-12,211
| -51% | -$186K |
|
|
PBCT
4884
CALL
DELISTED
People's United Financial Inc
PBCT
| $194K | ﹤0.01% |
12,400
-6,200
| -33% | -$97K |
|
|
ZAGG
4885
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $194K | ﹤0.01% |
30,864
-25,506
| -45% | -$165K |
|
4886
Bar Harbor Bankshares
BHB
$680M
| $193K | ﹤0.01% |
7,772
-2,377
| -23% | -$56.7K |
|
4887
CALL
ScottsMiracle-Gro
SMG
$3.98B
| $193K | ﹤0.01% |
1,900
-1,200
| -39% | -$126K |
|
4888
CALL
Universal Health Services
UHS
$10.3B
| $193K | ﹤0.01% |
1,300
-3,700
| -74% | -$531K |
|
|
AMNB
4889
DELISTED
American National Bankshares Inc
AMNB
| $193K | ﹤0.01% |
5,447
-1,669
| -23% | -$59.3K |
|
4890
CALL
iShares MSCI ACWI ETF
ACWI
$32.8B
| $192K | ﹤0.01% |
2,600
-23,100
| -90% | -$1.69M |
|
4891
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
| $192K | ﹤0.01% |
1,750
| – | – |
|
4892
iShares MSCI Taiwan ETF
EWT
$10.2B
| $192K | ﹤0.01% |
5,312
-146,751
| -97% | -$5.17M |
|
4893
CALL
Hecla Mining
HL
$9.64B
| $192K | ﹤0.01% |
108,900
-23,700
| -18% | -$42.7K |
|
4894
CALL
Realty Income
O
$58.9B
| $192K | ﹤0.01% |
2,580
-2,167
| -46% | -$152K |
|
4895
PAR Technology
PAR
$724M
| $192K | ﹤0.01% |
8,042
-1,364
| -15% | -$33.2K |
|
4896
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.23B
| $192K | ﹤0.01% |
3,500
| – | – |
|
4897
Tejon Ranch
TRC
$457M
| $192K | ﹤0.01% |
11,287
-2,728
| -19% | -$47.5K |
|
|
WBK
4898
DELISTED
Westpac Banking Corporation
WBK
| $192K | ﹤0.01% |
+9,574
| New | +$187K |
|
4899
Adaptive Biotechnologies
ADPT
$3.72B
| $191K | ﹤0.01% |
6,206
-8,125
| -57% | -$332K |
|
4900
Sierra Bancorp
BSRR
$529M
| $191K | ﹤0.01% |
7,213
-2,503
| -26% | -$64.4K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.